Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 144568
Gene Symbol: A2ML1
A2ML1
0.100 Biomarker disease HPO
Entrez Id: 16
Gene Symbol: AARS1
AARS1
0.100 Biomarker disease HPO
Entrez Id: 6833
Gene Symbol: ABCC8
ABCC8
0.100 Biomarker disease HPO
Entrez Id: 51099
Gene Symbol: ABHD5
ABHD5
0.100 Biomarker disease HPO
Entrez Id: 2181
Gene Symbol: ACSL3
ACSL3
0.010 GeneticVariation disease BEFREE Saethre-Chotzen syndrome (acrocephalo-syndactyly type III, ACS III) is an autosomal dominant craniosynostosis with brachydactyly, soft tissue syndactyly and facial dysmorphism including ptosis, facial asymmetry and prominent ear crura. 8988167 1997
Entrez Id: 58
Gene Symbol: ACTA1
ACTA1
0.100 Biomarker disease HPO
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.110 GeneticVariation disease BEFREE ACTB and ACTG1 mutations have recently been reported to cause Baraitser-Winter syndrome (BRWS) - a rare condition characterized by ptosis, colobomata, neuronal migration disorder, distinct facial anomalies and intellectual disability. 23756437 2014
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.110 Biomarker disease HPO
Entrez Id: 71
Gene Symbol: ACTG1
ACTG1
0.410 Biomarker disease GENOMICS_ENGLAND FISH localization of human cytoplasmic actin genes ACTB to 7p22 and ACTG1 to 17q25 and characterization of related pseudogenes. 8941379 1996
Entrez Id: 71
Gene Symbol: ACTG1
ACTG1
0.410 Biomarker disease HPO
Entrez Id: 71
Gene Symbol: ACTG1
ACTG1
0.410 GeneticVariation disease BEFREE ACTB and ACTG1 mutations have recently been reported to cause Baraitser-Winter syndrome (BRWS) - a rare condition characterized by ptosis, colobomata, neuronal migration disorder, distinct facial anomalies and intellectual disability. 23756437 2014
Entrez Id: 51412
Gene Symbol: ACTL6B
ACTL6B
0.100 Biomarker disease HPO
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.100 Biomarker disease HPO
Entrez Id: 23394
Gene Symbol: ADNP
ADNP
0.110 GeneticVariation disease BEFREE From a clinical standpoint, a differential diagnosis of patients with blepharophimosis should include ADNP mutations in addition to blepharophimosis ptosis epicanthus inversus syndrome, especially when intellectual disability is present. 28407407 2017
Entrez Id: 23394
Gene Symbol: ADNP
ADNP
0.110 Biomarker disease HPO
Entrez Id: 54936
Gene Symbol: ADPRS
ADPRS
0.100 Biomarker disease HPO
Entrez Id: 146
Gene Symbol: ADRA1D
ADRA1D
0.010 Biomarker disease BEFREE Because apraclonidine has an α-1 agonistic effect, α-1D adrenoceptor may contribute to apraclonidine's elevating effect in patients with blepharoptosis. 29634605 2019
Entrez Id: 122622
Gene Symbol: ADSS1
ADSS1
0.100 CausalMutation disease CLINVAR
Entrez Id: 10939
Gene Symbol: AFG3L2
AFG3L2
0.110 GeneticVariation disease BEFREE To identify the genetic cause of autosomal dominant spinocerebellar ataxia type 28 (SCA28) with ptosis in 2 Belgian families without AFG3L2 point mutations and further extend the clinical spectrum of SCA28 through the study of a brain autopsy, advanced MRI, and cell-based functional assays exploring the underlying disease mechanism. 24814845 2014
Entrez Id: 10939
Gene Symbol: AFG3L2
AFG3L2
0.110 Biomarker disease HPO
Entrez Id: 375790
Gene Symbol: AGRN
AGRN
0.100 Biomarker disease HPO
Entrez Id: 54806
Gene Symbol: AHI1
AHI1
0.100 Biomarker disease HPO
Entrez Id: 9049
Gene Symbol: AIP
AIP
0.100 Biomarker disease HPO
Entrez Id: 221264
Gene Symbol: AK9
AK9
0.100 Biomarker disease HPO
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.100 Biomarker disease HPO